GSTO2 and cancer: As expected, GSTO1*A140D, GSTO1*E155del, and GSTO2*N142D are the most common polymorphisms that have been investigated in cancer, but results remain inconsistent, as underlined in a previous meta-analysis performed by Xu et al. [46].